Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neurodegenerative Disease industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sanofi
Merck Serono
GlaxoSmithKline
Boehringer Ingelheim
Biogen Idec
UCB
Novartis
TEVA
By Type:
SSRIs
Dopamine Inhibitors
NMDA
By Application:
Amyotrophic Lateral Sclerosis
Parkinson’s Disease
Huntington Disease
Alzheimer’s Disease
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Neurodegenerative Disease Market Overview 2018-2029
-
1.1 China Neurodegenerative Disease Industry Development Overview
-
1.2 China Neurodegenerative Disease Industry Development History
-
1.3 China Neurodegenerative Disease Industry Market Size (2018-2029)
-
1.4 China Neurodegenerative Disease Market Analysis by Type from Production Side
-
1.4.1 China Neurodegenerative Disease Production Volume, Production Value and Growth Rate of SSRIs (2018-2029)
-
1.4.2 China Neurodegenerative Disease Production Volume, Production Value and Growth Rate of Dopamine Inhibitors (2018-2029)
-
1.4.3 China Neurodegenerative Disease Production Volume, Production Value and Growth Rate of NMDA (2018-2029)
-
1.5 China Neurodegenerative Disease Market Analysis by Application from Consumption End
-
1.5.1 China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Amyotrophic Lateral Sclerosis (2018-2029)
-
1.5.2 China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Parkinson’s Disease (2018-2029)
-
1.5.3 China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Huntington Disease (2018-2029)
-
1.5.4 China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Alzheimer’s Disease (2018-2029)
-
1.6 China Neurodegenerative Disease Market Analysis by Region
-
1.6.1 North China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
Chapter 2 China Neurodegenerative Disease Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Neurodegenerative Disease Market Status and Competition at home and abroad in 2023
-
2.2.2 China Neurodegenerative Disease Market Status and Competition Analysis in 2023
-
2.2.3 China Neurodegenerative Disease Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Neurodegenerative Disease Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Neurodegenerative Disease Industry Development
Chapter 3 Neurodegenerative DiseaseIndustry Chain Analysis
-
3.1 Neurodegenerative Disease Industry Chain
-
3.2 Neurodegenerative Disease Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Neurodegenerative Disease Market
-
3.3 Neurodegenerative Disease Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Neurodegenerative Disease Market
Chapter 4 China Neurodegenerative Disease Market, by Type
-
4.1 China Neurodegenerative Disease Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Neurodegenerative Disease Total Production Volume and Growth Rate from Production Side
-
4.5 China Neurodegenerative Disease Production Volume and Growth Rate, by Type
-
4.5.1 China Neurodegenerative Disease Production Volume and Growth Rate of SSRIs
-
4.5.2 China Neurodegenerative Disease Production Volume and Growth Rate of Dopamine Inhibitors
-
4.5.3 China Neurodegenerative Disease Production Volume and Growth Rate of NMDA
Chapter 5 China Neurodegenerative Disease Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Neurodegenerative Disease Total Market Size and Growth Rate from Consumption End
-
5.5 China Neurodegenerative Disease Market Size and Growth Rate, by Application
-
5.5.1 China Neurodegenerative Disease Market Size and Growth Rate of Amyotrophic Lateral Sclerosis
-
5.5.2 China Neurodegenerative Disease Market Size and Growth Rate of Parkinson’s Disease
-
5.5.3 China Neurodegenerative Disease Market Size and Growth Rate of Huntington Disease
-
5.5.4 China Neurodegenerative Disease Market Size and Growth Rate of Alzheimer’s Disease
Chapter 6 China Neurodegenerative Disease Market, by Region
-
6.1 China Neurodegenerative Disease Production Volume and Production Value, by Region
-
6.2 China Neurodegenerative Disease Sales Volume and Sales Value, by Region
Chapter 7 North China Neurodegenerative Disease Market Analysis
-
7.1 North China Neurodegenerative Disease Market, by Type
-
7.2 North China Neurodegenerative Disease Market, by Application
Chapter 8 Central China Neurodegenerative Disease Market Analysis
-
8.1 Central China Neurodegenerative Disease Market, by Type
-
8.2 Central China Neurodegenerative Disease Market, by Application
Chapter 9 South China Neurodegenerative Disease Market Analysis
-
9.1 South China Neurodegenerative Disease Market, by Type
-
9.2 South China Neurodegenerative Disease Market, by Application
Chapter 10 East China Neurodegenerative Disease Market Analysis
-
10.1 East China Neurodegenerative Disease Market, by Type
-
10.2 East China Neurodegenerative Disease Market, by Application
Chapter 11 Northeast China Neurodegenerative Disease Market Analysis
-
11.1 Northeast China Neurodegenerative Disease Market, by Type
-
11.2 Northeast China Neurodegenerative Disease Market, by Application
Chapter 12 Southwest China Neurodegenerative Disease Market Analysis
-
12.1 Southwest China Neurodegenerative Disease Market, by Type
-
12.2 Southwest China Neurodegenerative Disease Market, by Application
Chapter 13 Northwest China Neurodegenerative Disease Market Analysis
-
13.1 Northwest China Neurodegenerative Disease Market, by Type
-
13.2 Northwest China Neurodegenerative Disease Market, by Application
Chapter 14 Company Profiles
-
14.1 Sanofi
-
14.1.1 Sanofi Company Profile
-
14.1.2 Sanofi Neurodegenerative Disease Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck Serono
-
14.2.1 Merck Serono Company Profile
-
14.2.2 Merck Serono Neurodegenerative Disease Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Profile
-
14.3.2 GlaxoSmithKline Neurodegenerative Disease Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Boehringer Ingelheim
-
14.4.1 Boehringer Ingelheim Company Profile
-
14.4.2 Boehringer Ingelheim Neurodegenerative Disease Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Biogen Idec
-
14.5.1 Biogen Idec Company Profile
-
14.5.2 Biogen Idec Neurodegenerative Disease Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 UCB
-
14.6.1 UCB Company Profile
-
14.6.2 UCB Neurodegenerative Disease Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Novartis
-
14.7.1 Novartis Company Profile
-
14.7.2 Novartis Neurodegenerative Disease Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 TEVA
-
14.8.1 TEVA Company Profile
-
14.8.2 TEVA Neurodegenerative Disease Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Neurodegenerative Disease Industry Research Conclusions
-
15.2 Neurodegenerative Disease Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Neurodegenerative Disease Industry Market Size (2018-2029)
-
Figure China Neurodegenerative Disease Production Volume, Production Value and Growth Rate of SSRIs (2018-2029)
-
Figure China Neurodegenerative Disease Production Volume, Production Value and Growth Rate of Dopamine Inhibitors (2018-2029)
-
Figure China Neurodegenerative Disease Production Volume, Production Value and Growth Rate of NMDA (2018-2029)
-
Figure China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Amyotrophic Lateral Sclerosis (2018-2029)
-
Figure China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Parkinson’s Disease (2018-2029)
-
Figure China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Huntington Disease (2018-2029)
-
Figure China Neurodegenerative Disease Sales Volume, Sales Value and Growth Rate of Alzheimer’s Disease (2018-2029)
-
Figure North China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
Figure Central China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
Figure South China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
Figure East China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Neurodegenerative Disease Market Size and Growth Rate from 2018-2029
-
Figure Neurodegenerative Disease Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Neurodegenerative Disease Market Share by Type in 2018
-
Figure China Neurodegenerative Disease Market Share by Type in 2023
-
Figure China Neurodegenerative Disease Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Neurodegenerative Disease Production Volume and Growth Rate of SSRIs (2018-2023)
-
Figure China Neurodegenerative Disease Production Volume and Growth Rate of Dopamine Inhibitors (2018-2023)
-
Figure China Neurodegenerative Disease Production Volume and Growth Rate of NMDA (2018-2023)
-
Figure China Neurodegenerative Disease Market Share by Application in 2018
-
Figure China Neurodegenerative Disease Market Share by Application in 2023
-
Figure China Neurodegenerative Disease Total Market Size and Growth Rate from Consumption End
-
Figure China Neurodegenerative Disease Market Size and Growth Rate of Amyotrophic Lateral Sclerosis (2018-2023)
-
Figure China Neurodegenerative Disease Market Size and Growth Rate of Parkinson’s Disease (2018-2023)
-
Figure China Neurodegenerative Disease Market Size and Growth Rate of Huntington Disease (2018-2023)
-
Figure China Neurodegenerative Disease Market Size and Growth Rate of Alzheimer’s Disease (2018-2023)
-
Table China Neurodegenerative Disease Production Volume by Region (2018-2023)
-
Table China Neurodegenerative Disease Production Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Disease Production Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Disease Production Value by Region (2018-2023)
-
Table China Neurodegenerative Disease Production Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Disease Production Value Share by Region (2018-2023)
-
Table China Neurodegenerative Disease Sales Volume by Region (2018-2023)
-
Table China Neurodegenerative Disease Sales Volume Share by Region (2018-2023)
-
Figure China Neurodegenerative Disease Sales Volume Share by Region (2018-2023)
-
Table China Neurodegenerative Disease Sales Value by Region (2018-2023)
-
Table China Neurodegenerative Disease Sales Value Share by Region (2018-2023)
-
Figure China Neurodegenerative Disease Sales Value Share by Region (2018-2023)
-
Table North China Neurodegenerative Disease Production Volume by Type (2018-2023)
-
Table North China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Figure North China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Table North China Neurodegenerative Disease Sales Volume by Application (2018-2023)
-
Table North China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Figure North China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Table Central China Neurodegenerative Disease Production Volume by Type (2018-2023)
-
Table Central China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Figure Central China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Table Central China Neurodegenerative Disease Sales Volume by Application (2018-2023)
-
Table Central China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Figure Central China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Table South China Neurodegenerative Disease Production Volume by Type (2018-2023)
-
Table South China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Figure South China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Table South China Neurodegenerative Disease Sales Volume by Application (2018-2023)
-
Table South China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Figure South China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Table East China Neurodegenerative Disease Production Volume by Type (2018-2023)
-
Table East China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Figure East China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Table East China Neurodegenerative Disease Sales Volume by Application (2018-2023)
-
Table East China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Figure East China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Table Northeast China Neurodegenerative Disease Production Volume by Type (2018-2023)
-
Table Northeast China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Figure Northeast China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Table Northeast China Neurodegenerative Disease Sales Volume by Application (2018-2023)
-
Table Northeast China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Table Southwest China Neurodegenerative Disease Production Volume by Type (2018-2023)
-
Table Southwest China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Figure Southwest China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Table Southwest China Neurodegenerative Disease Sales Volume by Application (2018-2023)
-
Table Southwest China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Table Northwest China Neurodegenerative Disease Production Volume by Type (2018-2023)
-
Table Northwest China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Figure Northwest China Neurodegenerative Disease Production Volume Share by Type (2018-2023)
-
Table Northwest China Neurodegenerative Disease Sales Volume by Application (2018-2023)
-
Table Northwest China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Neurodegenerative Disease Sales Volume Share by Application (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
Table Merck Serono Company Profile
-
Table Merck Serono Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
Table Biogen Idec Company Profile
-
Table Biogen Idec Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
Table UCB Company Profile
-
Table UCB Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
Table TEVA Company Profile
-
Table TEVA Neurodegenerative Disease Revenue, Price and Gross (2018-2023)
-
